Clinical Trial Update: Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of Benmelstobart Injection and Anlotinib hydrochloride capsules for advanced or unresectable alveolar soft-p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Soft Part Sarcoma

Drugs mentioned

• Anlotinib hydrochloride capsules (anlotinib hydrochloride)
• Benmelstobart Injection (Benmelstobart)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Alveolar Soft Part Sarcoma | Phase 2 | Status: RECRUITING